In fact, PTN has been suggested to be a druggable target for metabolic disorders [15] as it is involved in the crosstalk between white and brown adipose tissue regulating thermogenesis [13,14], and in the liver accumulation of lipids in high-fat diet-induced obesity [13]. The gene discussed is PTN; the disease is metabolic disease.